Skip to menu Skip to content Skip to footer
Dr Christine Staatz
Dr

Christine Staatz

Email: 
Phone: 
+61 7 334 61974

Overview

Background

Christine graduated with a Bachelor of Pharmacy degree (honours class 1) from the University of Queensland in 1996.

She registered as a pharmacist in Australia in 1997 and in the United Kingdom in 2003 and has worked at the Redlands, Princess Alexandra and Wesley Hospitals in Brisbane and the Western Infirmary in Glasgow. In 2002 she was awarded a PhD from the University of Queensland, with a thesis focusing on improving usage of the immunosuppressant agent tacrolimus in solid organ transplant recipients.

In 2004 she was the recipient of a National Health and Medical Research Council (NHMRC) Neil Hamilton Fairley fellowship. This award enabled her to training overseas in the field of Pharmacometrics within the Department of Medicine and Therapeutics at the University of Glasgow (Scotland) and the Department of Pharmaceutical Biosciences at Uppsala University (Sweden).

On her return to Brisbane, Christine was the recipient of a Lions Medical Research Fellowship and was the chief investigator on a three year NHMRC Project Grant. She has also been a team member on an Amgen-Transplant Society of Australia and New Zealand Research Grant and a Cellcept Australia Research Grant. Over her research career Christine has attracted grants and awards totaling more than 2 million AUD from various funding agencies.

Research Interests

Christine has a wide range of interests in the fields of Quality Use of Medicine and Pharmacometrics. Her work to date has primarily been directed towards optimising usage of immunosuppressant drugs in solid organ transplant recipients and antibiotics in patients with life-threatening infections.

Christine has published over 75 peer reviewed papers and 90 conference abstracts on these topics. Her publications have been cited on more than 3200 occasions, with twelve cited more than 50 times.

Christine has successfully supervised to completion fourteen higher research degree students and enjoys helping students meet their career goals.

Christine’s current projects include:

  • Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
  • Comparing the efficacy and safety of continuous versus intermittent administration of beta-lactams in critically ill patients
  • Examining the relationship between immunosuppression and non-melanoma skin cancer in renal transplant recipients
  • Improving individualisation of immunosuppressant therapy in adult kidney transplant recipients
  • Improving gentamycin dosing in paediatric oncology patients
  • Examining tobramycin monitoring in cystic fibrosis patients in Australia and the United Kingdom
  • Investigating the relationship between prednisolone exposure and drug-related toxicity in paediatric and adult kidney transplant recipients
  • Comparing different therapeutic drug monitoring methods for dosage adjustment of once daily intravenous tobramycin treatment in children with cystic fibrosis

Projects currently available for interested research higher degree students include:

  • Dose optimisation of busulfan in paediatric bone marrow transplant recipients
  • Investigating the relationship between immunosupressant exposure and drug-related toxicity in transplant recipients
  • Examining Bayesian forecasting methods to predict immunosuppressant exposure
  • Examining the international use of immunosuppressant and anti-rheumatic drugs
  • Examining the influence of plasma exchange on immunosuppressant drug exposure

Christine invites potential honours and post-graduate students to contact her via email to discuss research opportunities.

Teaching interests

Co-ordinates:

  • PHRM3052- Biological Fate of Drugs

Teaches in:

  • PHRM3052- Biological Fate of Drugs
  • PHRM3011- Quality Use of Medicines

Availability

Dr Christine Staatz is:
Available for supervision

Qualifications

  • Bachelor, The University of Queensland
  • Bachelor (Honours) of Pharmacy, The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Works

Search Professor Christine Staatz’s works on UQ eSpace

252 works between 1998 and 2025

61 - 80 of 252 works

2020

Conference Publication

Examining tacrolimus exposure in paediatric liver transplant recipients.

Yu Oi Sze Isy, Steward-Harrison, L. and Staatz, C. E. (2020). Examining tacrolimus exposure in paediatric liver transplant recipients.. World Conference of Paediatric Gastroenterology, Hepatology and Nutrition, Copenhagen, Denmark, June 2020.

Examining tacrolimus exposure in paediatric liver transplant recipients.

2020

Conference Publication

The burden of venepuncture for kidney transplant patients and interest in possible solutions.

Scuderi, C., Parker, S., John, G., McWhinney, B., Ungerer, J., Mallett, A., Roberts, J., Healy, H. and Staatz, C.E. (2020). The burden of venepuncture for kidney transplant patients and interest in possible solutions. . Society of Hospital Pharmacists of Australia, Online, 21-22 November 2020.

The burden of venepuncture for kidney transplant patients and interest in possible solutions.

2020

Conference Publication

Interest in possible alternative methods to venepuncture-based monitoring in kidney transplant patients.

Scuderi, C., Parker, S., John, G., McWhinney, B., Ungerer, J., Mallett, A., Roberts, J., Healy, H. and Staatz, C.E. (2020). Interest in possible alternative methods to venepuncture-based monitoring in kidney transplant patients. . RBWH Symposium, Brisbane, QLD Australia, 7-11 December 2020.

Interest in possible alternative methods to venepuncture-based monitoring in kidney transplant patients.

2020

Conference Publication

Pharmacokinetics of iIntravenous busulfan in children undergoing haematopoietic stem cell transplant and evidence for non-linear pharmacokinetic behavior

Lawson, R., Fraser, C., Staatz, C. E. and Hennig, S. (2020). Pharmacokinetics of iIntravenous busulfan in children undergoing haematopoietic stem cell transplant and evidence for non-linear pharmacokinetic behavior. Australian & New Zealand Children’s Haematology/Oncology Group Annual Scientific Meeting, Melbourne, VIC Australia, 11-13th June 2020.

Pharmacokinetics of iIntravenous busulfan in children undergoing haematopoietic stem cell transplant and evidence for non-linear pharmacokinetic behavior

2019

Journal Article

Investigation of the association between total and free plasma and saliva mycophenolic acid concentrations following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients

Brooks, Emily, Tett, Susan E., Isbel, Nicole M., McWhinney, Brett and Staatz, Christine E. (2019). Investigation of the association between total and free plasma and saliva mycophenolic acid concentrations following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients. Clinical Drug Investigation, 39 (12), 1175-1184. doi: 10.1007/s40261-019-00844-y

Investigation of the association between total and free plasma and saliva mycophenolic acid concentrations following administration of enteric-coated mycophenolate sodium in adult kidney transplant recipients

2019

Journal Article

Prednisolone concentrations in plasma (total and unbound) and saliva of adult kidney transplant recipients

Brooks, Emily, Tett, Susan E., Isbel, Nicole M., McWhinney, Brett and Staatz, Christine E. (2019). Prednisolone concentrations in plasma (total and unbound) and saliva of adult kidney transplant recipients. Therapeutic Drug Monitoring, 41 (6), 755-760. doi: 10.1097/FTD.0000000000000687

Prednisolone concentrations in plasma (total and unbound) and saliva of adult kidney transplant recipients

2019

Journal Article

Optimizing mycophenolic acid exposure in kidney transplant recipients: time for target concentration intervention

Metz, David K., Holford, Nick, Kausman, Joshua Y., Walker, Amanda, Cranswick, Noel, Staatz, Christine E., Barraclough, Katherine A. and Ierino, Francesco (2019). Optimizing mycophenolic acid exposure in kidney transplant recipients: time for target concentration intervention. Transplantation, 103 (10), 2012-2030. doi: 10.1097/TP.0000000000002762

Optimizing mycophenolic acid exposure in kidney transplant recipients: time for target concentration intervention

2019

Journal Article

Pharmacometrics in Australasia — twenty years of population approach group of Australia and New Zealand

Hennig, Stefanie, Hannam, Jacqueline A., Kirkpatrick, Carl M.J., Staatz, Christine E., Holford, Sam, Duffull, Stephen B., Al-Sallami, Hesham S., Charles, Bruce G., Holford, Nick and Foster, David J.R. (2019). Pharmacometrics in Australasia — twenty years of population approach group of Australia and New Zealand. CPT: Pharmacometrics and Systems Pharmacology, 8 (10), 701-704. doi: 10.1002/psp4.12460

Pharmacometrics in Australasia — twenty years of population approach group of Australia and New Zealand

2019

Journal Article

An evaluation of the user‐friendliness of Bayesian Forecasting programs in a clinical setting

Kumar, Alzana A., Burgard, Marc, Stacey, Sonya, Sandaradura, Indy, Lai, Tony, Coorey, Christine, Cincunegui, Marisol, Staatz, Christine E. and Hennig, Stefanie (2019). An evaluation of the user‐friendliness of Bayesian Forecasting programs in a clinical setting. British Journal of Clinical Pharmacology, 85 (10) bcp.14066, 2436-2441. doi: 10.1111/bcp.14066

An evaluation of the user‐friendliness of Bayesian Forecasting programs in a clinical setting

2019

Journal Article

O11 Characterising the pharmacokinetics of phenobarbitone in neonates to facilitate future individualised dosing

Williams, A, Donovan, T, Charles, B and Staatz, C (2019). O11 Characterising the pharmacokinetics of phenobarbitone in neonates to facilitate future individualised dosing. Archives of Disease in Childhood, 104 (6). doi: 10.1136/archdischild-2019-esdppp.11

O11 Characterising the pharmacokinetics of phenobarbitone in neonates to facilitate future individualised dosing

2019

Journal Article

Characterizing the pharmacokinetics and pharmacodynamics of immunosuppressant medicines and patient outcomes in elderly renal transplant patients

Cossart, Amelia R., Cottrell, W. Neil, Campbell, Scott B., Isbel, Nicole M. and Staatz, Christine E. (2019). Characterizing the pharmacokinetics and pharmacodynamics of immunosuppressant medicines and patient outcomes in elderly renal transplant patients. Translational Andrology and Urology, 8 (S2), S198-S213. doi: 10.21037/tau.2018.10.16

Characterizing the pharmacokinetics and pharmacodynamics of immunosuppressant medicines and patient outcomes in elderly renal transplant patients

2019

Journal Article

Quizzing for success: evaluation of the impact of feedback quizzes on the experiences and academic performance of undergraduate students in two clinical pharmacokinetics courses

Hennig, Stefanie, Staatz, Christine E., Bond, Jacqueline A., Leung, Debbie and Singleton, Judith (2019). Quizzing for success: evaluation of the impact of feedback quizzes on the experiences and academic performance of undergraduate students in two clinical pharmacokinetics courses. Currents in Pharmacy Teaching and Learning, 11 (7), 742-749. doi: 10.1016/j.cptl.2019.03.014

Quizzing for success: evaluation of the impact of feedback quizzes on the experiences and academic performance of undergraduate students in two clinical pharmacokinetics courses

2019

Conference Publication

Saliva prednisolone measurements in adult kidney transplant recipients

Staatz, C. E., Tett, S. E., Isbel, N., Mc Whinney, B. and Brooks, E. (2019). Saliva prednisolone measurements in adult kidney transplant recipients. International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Foz de Iguassu, Brazil, September 2019.

Saliva prednisolone measurements in adult kidney transplant recipients

2019

Conference Publication

A population pharmacokinetic model of phenobarbitone in neonates to determine oral bioavailability and facilitate individualised dosing

Williams, A., Donovan, T., Charles, B. and Staatz, C. E. (2019). A population pharmacokinetic model of phenobarbitone in neonates to determine oral bioavailability and facilitate individualised dosing. Population Approach Group Australia and New Zealand, Adelaide, SA, Australia, February 2019.

A population pharmacokinetic model of phenobarbitone in neonates to determine oral bioavailability and facilitate individualised dosing

2019

Journal Article

Investigating barriers to immunosuppressant medication adherence in renal transplant patients

Cossart, Amelia R., Staatz, Christine E., Campbell, Scott B., Isbel, Nicole M. and Cottrell, W. Neil (2019). Investigating barriers to immunosuppressant medication adherence in renal transplant patients. Nephrology, 24 (1), 102-110. doi: 10.1111/nep.13214

Investigating barriers to immunosuppressant medication adherence in renal transplant patients

2019

Conference Publication

Utilisation of erythropoietin stimulating agents and immunosuppressants in chronic kidney disease patients.

Stanley, K., Gardiner, K., Schultz, K. and Staatz, C. E. (2019). Utilisation of erythropoietin stimulating agents and immunosuppressants in chronic kidney disease patients.. Australian Pharmaceutical Sciences Association, Melbourne, Australia, December 2019.

Utilisation of erythropoietin stimulating agents and immunosuppressants in chronic kidney disease patients.

2019

Conference Publication

A population pharmacokinetic model of phenobarbitone in neonates to determine oral bioavailability and facilitate individualised dosing

Williams, A., Donovan, T., Charles B. and Staatz, C. E. (2019). A population pharmacokinetic model of phenobarbitone in neonates to determine oral bioavailability and facilitate individualised dosing. European Society of Developmental, Perinatal and Paediatric Pharmacology Conference, Basel, Switzerland, 28-30 May 2019.

A population pharmacokinetic model of phenobarbitone in neonates to determine oral bioavailability and facilitate individualised dosing

2019

Conference Publication

Effect of immunosuppressant prescribing patterns on patient outcomes in elderly Australasian kidney transplant recipients

Cossart, A., Cottrell, N., Mcstea, M., Isbel, N., Campbell, S. and Staatz, C. E. (2019). Effect of immunosuppressant prescribing patterns on patient outcomes in elderly Australasian kidney transplant recipients. Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Queenstown, New Zealand, November 2019.

Effect of immunosuppressant prescribing patterns on patient outcomes in elderly Australasian kidney transplant recipients

2018

Journal Article

Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life?

Gardiner, Kyle M., Tett, Susan E. and Staatz, Christine E. (2018). Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life?. Drugs in R & D, 18 (4), 271-282. doi: 10.1007/s40268-018-0254-8

Is conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium justifiable for gastrointestinal quality of life?

2018

Journal Article

Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit

Adewumi, Adeleke D., Staatz, Christine E., Hollingworth, Samantha A., Connor, Jason P. and Alati, Rosa (2018). Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit. Drug Safety, 41 (11), 1-11. doi: 10.1007/s40264-018-0687-6

Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit

Funding

Current funding

  • 2024 - 2026
    Exploring the impact of BUsulfan METabolites on busulfan clearance, exposure and patient outcomes following Haematopoietic Stem Cell Transplantation (BU-MET-HSCT). (QHCRF administered by CHQ HHS)
    Children's Health Queensland Hospital and Health Service
    Open grant

Past funding

  • 2019 - 2020
    Evaluating immunosuppressant medicines in elderly renal transplant recipients
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2019
    Bu4DayPK - Analysis of once daily IV Busulfan in paediatric HSCT patients
    Children's Health Queensland Hospital and Health Service
    Open grant
  • 2018 - 2019
    Innovative blood sampling to reduce the burden of long-term treatment for kidney transplant recipients
    Metro North Hospital and Health Service
    Open grant
  • 2014
    Designing optimal dosing regimens for immunosuppressant medications
    Queensland Pharmacy Research Trust
    Open grant
  • 2010 - 2011
    Examining the relationship between immunosuppression and BK virus infection in adult kidney transplant recipients
    UQ New Staff Research Start-Up Fund
    Open grant
  • 2010
    Analytical instrumentation enabling rapid compound separation and chemical structure analysis via mass fingerprinting
    UQ Major Equipment and Infrastructure
    Open grant
  • 2008 - 2011
    Lions Medical Research Foundation Fellowship - Tailoring doses of the newer immunosuppressant drugs to improve outcomes after transplant
    Lions Medical Research Foundation
    Open grant
  • 2008 - 2011
    Improved patient outcomes through dosage individualisation of the newer immunosuppressant drugs
    NHMRC Project Grant
    Open grant
  • 2008
    UQ Travel Awards Category 2 - Christine Staatz
    UQ Travel Grants Scheme
    Open grant
  • 2004 - 2008
    NEIL HAMILTON FAIRLEY FELLOWSHIP: Population Pharmacokinetic And Pharmacodynamic Modelling Of The Newer Immunosuppressant Drugs
    NHMRC Training (Postdoctoral) Fellowship
    Open grant

Supervision

Availability

Dr Christine Staatz is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Dr Christine Staatz's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au